CHEN LABORATORY
Bacterial adaptation and Antibody function
CHEN LABORATORY
Bacterial adaptation and Antibody function
duanqy@szbl.ac.cn
2023 to Present Institute of Infectious Diseases, Shenzhen Bay Laboratory, China.
2019 to 2022 Ph.D., Pathogen Biology, Fundan University, School of Basic Medical Science, China.
2016 to 2019 M.S., Veterinary Science, Chinese Academy of Agricultural Science, Shanghai Veterinary Research Institute, China.
2011 to 2015 B.S., Animal and Plant Quarantine, Shanxi Agricultural University, China.
Publication
1) Duan Q, Xia S, Jiao F, Wang Q, Wang R, Lu L*, Jiang S*, Xu W*. A modified fibronectin type III domain-conjugated, long-acting pan-coronavirus fusion inhibitor with extended half-life. Viruses. 2022, 14(4), 655
2) Xu W#, Cong Z#, Duan Q#, Wang Q, Su S, Wang R, Lu L, Xue J, Jiang S. A protein-based, long-acting HIV-1 fusion inhibitor with an improved pharmacokinetic profile. Pharmaceuticals. 2022, 15(4), 424
3) Xue S, Xu W*, Wang L, Wang X, Duan Q, Calcul L, Wang S, Liu W, Sun X, Lu L*, Jiang S*, and Cai J*. An HR2-Mimicking Sulfonyl-γ-AApeptide Is a Potent Pan-coronavirus Fusion Inhibitor with Strong Blood–Brain Barrier Permeability, Long Half-Life, and Promising Oral Bioavailability. ACS Central Science.2023. DOI: 10.1021/acscentsci.3c00313
Address：Gaoke International Innovation Center, Guangming District,
Shenzhen, Guangdong Province
Copyright All Rights Reserved【粤 ICP 备 19032884号】|Powered by szweb|Designed by smarta
E-mall：xinhaichen@szbl.ac.cn
PI contact person：Xinhai Chen